Wintrust Financial Co. (NASDAQ:WTFCM – Get Rating) was down 0.1% on Tuesday . The company traded as low as $25.25 and last traded at $25.45. Approximately 5,830 shares changed hands during mid-day trading, a decline of 15% from the average daily volume of 6,846 shares. The stock had previously closed at $25.48.
Wintrust Financial Stock Down 0.1 %
The business has a 50 day moving average price of $25.30 and a two-hundred day moving average price of $24.80.
Get Wintrust Financial alerts:Wintrust Financial Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Saturday, April 15th. Stockholders of record on Saturday, April 1st will be paid a $0.41 dividend. This represents a $1.64 dividend on an annualized basis and a dividend yield of 6.44%. The ex-dividend date is Thursday, March 30th.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Wintrust Financial stock. Connectus Wealth LLC bought a new position in shares of Wintrust Financial Co. (NASDAQ:WTFCM – Get Rating) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 276,391 shares of the company's stock, valued at approximately $6,752,000.
Wintrust Financial Company Profile
(Get Rating)
Wintrust Financial Corporation operates as a financial holding company. It operates in three segments: Community Banking, Specialty Finance, and Wealth Management. The Community Banking segment offers non-interest bearing deposits, non-brokered interest-bearing transaction accounts, and savings and domestic time deposits; home equity, consumer, and real estate loans; safe deposit facilities; and automatic teller machine (ATM), online and mobile banking, and other services.
Read More
- Get a free copy of the StockNews.com research report on Wintrust Financial (WTFCM)
- Under-the-Radar Azul SA Takes Flight on Robust Travel Demand
- Market Gets "Powelled": S&P 500 Confirms Resistance
- Rivian Plummets, But Is This 2023's Greatest Buying Opportunity?
- Ulta Insiders Hold Tight: Sell-Siders Buy
- Potential Earnings Have Rated Ambrx Biopharma a Moderate Buy
Receive News & Ratings for Wintrust Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wintrust Financial and related companies with MarketBeat.com's FREE daily email newsletter.